An open-label pilot study with high-dose thiamine in Parkinson's disease.
Neural Regen Res. 2016 Mar; 11(3):406-7.NR

Links

PMC Free PDF

Authors+Show Affiliations

Costantini A

Department of Neurological Rehabilitation, "Villa Immacolata" Clinic, Viterbo, Italy.

Fancellu R

Unit of Neurology, IRCCS San Martino University Hospital IST, Genova, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27127471

Citation

Costantini, Antonio, and Roberto Fancellu. "An Open-label Pilot Study With High-dose Thiamine in Parkinson's Disease." Neural Regeneration Research, vol. 11, no. 3, 2016, pp. 406-7.

Costantini A, Fancellu R. An open-label pilot study with high-dose thiamine in Parkinson's disease. Neural Regen Res. 2016;11(3):406-7.

Costantini, A., & Fancellu, R. (2016). An open-label pilot study with high-dose thiamine in Parkinson's disease. Neural Regeneration Research, 11(3), 406-7. https://doi.org/10.4103/1673-5374.179047

Costantini A, Fancellu R. An Open-label Pilot Study With High-dose Thiamine in Parkinson's Disease. Neural Regen Res. 2016;11(3):406-7. PubMed PMID: 27127471.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - An open-label pilot study with high-dose thiamine in Parkinson's disease. AU - Costantini,Antonio, AU - Fancellu,Roberto, PY - 2016/4/30/entrez PY - 2016/4/30/pubmed PY - 2016/4/30/medline SP - 406 EP - 7 JF - Neural regeneration research JO - Neural Regen Res VL - 11 IS - 3 SN - 1673-5374 UR - https://www.unboundmedicine.com/medline/citation/27127471/full_citation DB - PRIME DP - Unbound Medicine ER -

Tags

An open-label pilot study with high-dose thiamine in Parkinson's disease.Neural Regen Res. 2016 Mar; 11(3):406-7.NR